In addition, the mRNA level of LCP1 in liver tissue of NAFLD patients was strongly increased (300%) compare to the control group in a previous GWAS study (55), and Miller et al. The gene discussed is LCP1; the disease is metabolic dysfunction-associated steatotic liver disease.